XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation (Tables)
9 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Compensation Expense Information
The following table provides information regarding our stock-based compensation:
Three Months Ended December 31, Nine Months Ended December 31,
(In thousands)2023202220232022
Pre-tax stock-based compensation costs charged against income$2,449 $2,433 $10,283 $9,756 
Income tax benefit recognized on compensation costs$241 $49 $910 $924 
Total fair value of options and RSUs vested during the period$— $63 $12,213 $10,352 
Cash received from the exercise of stock options$1,635 $5,684 $10,818 $7,173 
Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises$351 $731 $1,490 $3,626 
Summary of Restricted Shares A summary of the RSUs granted under the 2005 Plan and the 2020 Plan is presented below:
 
 
 
RSUs
 
Shares
(in thousands)
Weighted
Average
Grant-Date
Fair Value
Nine Months Ended December 31, 2022
Unvested at March 31, 2022440.9 $38.45 
Granted151.0 55.03 
Incremental performance shares 42.4 — 
Vested (223.4)32.09 
Forfeited(1.9)49.51 
Unvested at December 31, 2022409.0 47.17 
Vested at December 31, 2022108.5 36.54 
   
Nine Months Ended December 31, 2023
Unvested at March 31, 2023409.0 $47.17 
Granted157.1 62.06 
Incremental performance shares41.4 — 
Vested (205.0)43.17 
Forfeited(10.6)52.68 
Unvested at December 31, 2023391.9 54.43 
Vested at December 31, 2023110.2 38.77 
Fair Value of Options Granted
The fair value of each option award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions presented below:
 Nine Months Ended December 31,
 2023 2022
Expected volatility
30.2% - 31.6%
 
30.8% - 30.9%
Expected dividends$—  $— 
Expected term in years
6.0 to 7.0
 
6.0 to 7.0
Risk-free rate
3.6% to 4.1%
 
2.8% to 2.9%
Weighted average grant date fair value of options granted$23.79 $20.10 
Stock Option Activity
A summary of option activity under the 2005 Plan and the 2020 Plan is as follows:
 
 
 
 
Options
 
 
Shares
(in thousands)
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic
Value
(in thousands)
Nine Months Ended December 31, 2022
Outstanding at March 31, 20221,100.9 $40.62 
Granted197.6 54.48 
Exercised(200.2)35.82 
Forfeited(10.3)49.53 
Expired(0.8)44.33 
Outstanding at December 31, 20221,087.2 43.94 6.7$20,289 
Vested at December 31, 2022670.5 41.18 5.4$14,360 
Nine Months Ended December 31, 2023    
Outstanding at March 31, 20231,081.0 $43.96 
Granted131.1 61.81 
Exercised(268.9)40.23 
Forfeited (41.0)54.15 
Expired(2.8)54.47 
Outstanding at December 31, 2023899.4 47.18 6.2$12,703 
Vested at December 31, 2023606.2 43.23 5.0$10,903